Strategy

>

Latest News

Biopharma Business Check: Financing Review and Outlook
Biopharma Business Check: Financing Review and Outlook

February 13th 2025

A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and biotech ahead.

John Graham and Ross Maclean
Balancing the New Trend in HEOR Organizational Structure and Focus

February 13th 2025

The Teva Turnaround: Steering a Company Comeback
The Teva Turnaround: Steering a Company Comeback

February 11th 2025

Dan Rizzo
Preventing Silos During Product Launches: Q&A with Dan Rizzo

February 7th 2025

Tim Clark and Karen L Smith
Exploring the Advantages of Innovative Early Phase Trial Design

January 30th 2025

More News